As expected from previous studies, we observed a strong induction of the FHB1 mRNA
Thus, repaglinide may increase the risk of hypoglycemia in patients taking clopidogrel, and the concomitant use of both agents has been contraindicated since 2015 in Canada [8]
Avoid heavy cream versions
Originally developed as a diabetes medication, semaglutide is also FDA-approved for weight loss
Additionally, these recommendations help payers, policy makers, researchers, research funding organizations, and advocacy groups align their policies and resources and deliver optimal care for people living with diabetes
This guide is designed to give you a clear, practical answer